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Rapport de synthèse 
Implication des canaux Ca2+ de type L et des canaux KArP dans la protection 
induite par pacing dans un modèle de cœur embryonnaire soumis à l'anoxie-
réoxygénation. 
Contexte et but: le canal Ca2+ de type L, les canaux K+ du sarcolemme (sarcKArP) et 
de la mitochondrie (mitoKArP) interviennent dans le préconditionnement ischémique 
ou pharmacologique du myocarde. La présente étude cherche à déterminer dans 
quelle mesure ces canaux peuvent aussi jouer un rôle dans la cardioprotection 
induite par pacing. 
Méthodes : des cœurs d'embryons de poulet âgés de 4 jours ont été soumis in ovo à 
un pacing durant 12 heures, en pratiquant une stimulation électrique ventriculaire 
asynchrone intermittente à 110% de la fréquence cardiaque intrinsèque. Les cœurs 
contrôle (sham) et les cœurs stimulés ont ensuite été soumis in vitro à une période 
d'anoxie de 30 minutes, suivie d'une réoxygénation de 60 minutes. Les cœurs ont 
été exposés à l'agoniste du canal Ca2+ de type L (Bay-K-8644, BAY-K) ou à son 
bloqueur (vérapamil, VERAP), à l'antagoniste non sélectif des canaux KArP 
(glibenclamide, GLIB), ainsi qu'à l'agoniste du canal mitoKArP (diazoxide, DIAZO), ou 
à son antagoniste (5-hydroxydécanoate, 5-HD). L'électrocardiogramme, le délai 
électro-mécanique (DEM) reflétant le couplage excitation-contraction, ainsi que la 
contractilité myocardique ont été systématiquement déterminés pendant l'anoxie-
réoxygénation. 
Résultats: en normoxie, la fréquence cardiaque, l'intervalle QT, la conduction atrio-
ventriculaire, le DEM et le raccourcissement ventriculaires étaient identiques dans 
les cœurs sham et les cœurs stimulés. Par contre, au cours de la réoxygénation 
post-anoxique, les arythmies cessaient plus précocément et le DEM ventriculaire 
retrouvait plus rapidement son niveau initial dans les cœurs stimulés, comparés aux 
sham. Dans les cœurs sham, BAY-K (mais pas le VERAP), DIAZO (mais pas le 5-
HD) ou GLIB accéléraient la récupération du DEM ventriculaire, reproduisant ainsi la 
protection induite par le pacing. En revanche, aucun de ces agents n'affectait la 
récupération des cœurs stimulés. 
Conclusion : un pacing ventriculaire chronique et intermittent délivré à une fréquence 
quasi physiologique améliore la tolérance myocardique à une anoxie-réoxygénation 
ultérieure. L'approche pharmacologique a montré qu'une activation discrète du canal 
Ca2+ de type L, une inhibition du canal sarcKArP et/ou une ouverture du canal 
mitoKArP peuvent contribuer à la cardioprotection induite par le pacing. 
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L-Type Ca2+ and KATP Channels in Pacing-Induced Cardioprotection. Aims: The L-type 
Ca2+ channel, the sarcolemmal (sarcKATP ), and mitochondrial KATP (mitoKATP) channels are involved in 
myocardial preconditioning. We aimed at determining to what extent these channels can also participate 
in pacing-induced cardioprotection. 
Methods: Hearts of 4-day-old chick embryos were paced in ovo during 12 hour using asynchronous 
intermittent ventricular stimulation at 110% of the intrinsic rate. Sham operated and paced hearts were then 
submitted in vitro to anoxia (30 minutes) and reoxygenation (60 minutes). These hearts were exposed to L-
type Ca2+ channel agonist Bay-K-8644 (BAY-K) or blocker verapamil, nonselective KATP channel antagonist 
glibenclamide (GLIB), mitoKATP channel agonist diazoxide (DIAZO), or antagonist 5-hydroxydecanoate. 
Electrocardiogram, electromechanical delay (EMD) reftecting excitation-contraction (E-C) coupling, and 
contractility were determined. 
Results: Under normoxia, heart rate, QT duration, conduction, EMD, and ventricular shortening were 
similar in sham and paced hearts. During reoxygenation, arrhythmias ceased earlier and ventricular EMD 
recovered faster in paced hearts than in sham hearts. In sham hearts, BAY-K (but not verapamil), DIAZO 
(but not 5-hydroxydecanoate) or GLIB accelerated recovery ofventricular EMD, reproducing the pacing-
induced protection. By contrast, none of these agents further ameliorated recovery of the paced hearts. 
Conclusion: The protective effect of chronic asynchronous pacing at near physiological rate on ventricular 
E-C coupling appears to be associated with subtle activation of L-type Ca2+ channel, inhibition of sarcKATP 
channel, and/or opening of mitoKATP channel. ( J Cardiovasc Electrophysiol, Vol. 19, pp. 1196-1202, November 
2008) 
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Introduction 
Cardioprotection against ischemia-reperfusion injury can 
be achieved either by preconditioning the myocardium by 
brief ischemic episodes1•2 or by nonischemic means includ-
ing the use of pharmacological agents. 3.4 The beneficial ef-
fects can be measured in terms of reduction of infarct size, 
myocardial stunning, ultrastructural damages, and arrhyth-
mias. 5·6 Transient rapid ventricular pacing, in isolated or re-
peated episodes, has also been used as preconditioning stim-
ulus in order to improve the postischemic recovery of the 
heart.7 This technique was, however, proposed to act through 
the same signaling pathways as those involved in the "classi-
cal" ischemic preconditioning, as high contractile rates gen-
erate a relative state of hypoxia. Despite the recent major ad-
vances in pacing technology8 and the unquestionable benefits 
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afforded by the use of implantable pacing devices in patients 
with heart failure and cardiac dyssynchrony,9 the underlying 
protective mechanisms remain poorly defined. 
We have previously developed an embryonic chick heart 
model in which chronic intermittent ventricular pacing at near 
physiological rate over 12-48 hours rapidly results in hemo-
dynamic alterations (reduced end diastolic volume and stroke 
volume), 10 structural remodeling (wall thinning near pacing 
site), 11 metabolic remodeling (glycogen redistribution), re-
duction of ROS production upon reoxygenation, 10 and im-
provement offunctional recovery after anoxia-reoxygenation 
(amelioration of E-C coupling and less arrhythmias). 12 Sim-
ilarly, it has been recently shown that dyssynchronous ven-
tricular activation at physiological rate can also precondition 
the adult heart (rabbit) against ischemia-reperfusion injury. 13 
The role played by the L-type Ca2+ channel, the sarcolem-
mal (sarcKATP), and mitochondrial KATP (mitoKATP) chan-
nels, known otherwise to be involved in ischemic and phar-
macological preconditioning, 14- 17 remains to be investigated 
in the pacing-induced protection. Using the embryonic chick 
heart mode!, we aimed at determining to what extent pharma-
cological modulation of these channels affects the protection 
against posthypoxic injury afforded by pacing at near physi-
ological rate. 
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Figure 1. Experimental protocol. Ajier 12 hourventricularpacing or sham 
operation in ovo, the emb1yonic hearts (stage 25 HH) were isolated and 
subjected in vitro to anoxia (N2 , 30 minutes) and reoxygenation (air, 60 
minutes) in the presence or absence of agonists or antagonists ofinvestigated 
ion channels. ECG and mechanical recordings were pe1formed in vitro. At 
the end ofreoxygenation, hearts were dissected into atria (A), vellfricle (V), 
and conotnmcus (CT)for protein determinatio11. HR = heart rate. 
Material and Methods 
The investigation conforms with the Guide for the Care 
and Use of Laboratory Animais published by the US 
National Institutes of Health (NIH Publication No. 85-23, 
revised 1996). 
Pharmacological Agents 
Bay-K-8644 (BAY-K), 5-hydroxydecanoate (5-HD), dia-
zoxide (DIAZO), and glibenclamide (GLIB) were obtained 
from Sigma and verapamil (Isoptin, VERAP) from Knoll AG, 
Ludwigshafen, Germany. 
In Ovo Pacing 
Fertilized eggs from Lohman Brown hens were incubated 
96 hours at 38°C and 90% humidity to obtain embryo at 
stage 24 HH, according to Hamburger-Hamilton. 18 Pacing of 
the heart was performed through a window of the shell for 
PACING 
\ 
12 hours inside a thermostabilized incubator (37°C, 70% hu-
midity) integrating a dissecting microscope, a micromanip-
ulator, and a stimulator (Medtronic 5880 A, Medtronic Inc., 
Minneapolis, MN, USA) as previously described.10 Pacing 
protocol consisted of an asynchronous cathodic stimulation 
at the surface of the ventricular apex (after opening of the 
embryonic pericardium), with alternating pattern of stimula-
tion, that is, 5 minutes ON - 10 minutes OFF (Fig. 1). The 
impulse duration was 2 ms and the stimulation frequency was 
chosen as 110% of the intrinsic heart rate with supraliminar 
intensity (2x threshold of capture, tested visually). We used 
platinum wire (0 0.2 mm) as cathode, the anode being placed 
against the back of the embryo, following the electrical axis 
of the heart. The effective pacing time was 4 hours. Sham 
group consisted of 4-day-old embryos growing for 12 hours 
in the same conditions, that is, with opened pericardium and 
positioned electrodes, but without pacing. At the end of the 
pacing period, embryos reached stage 25 HH. 
In Vitro Anoxia-Reoxygenation 
After the in ovo pacing, the spontaneously beating hearts 
were carefully excised and placed in the culture compart-
ment (300 µ,L) of an airtight stainless steel chamber, ther-
mostabilized at 37.5°C, and equipped with two windows for 
observation and measurements, as previously described. 19-21 
This compartment was separated from the gas compartment 
by a thin (15 µ,m), transparent and gas-permeable silicone 
membrane (RTV 141, Rhône-Poulenc, Lyon, France), the 
heart being slightly flattened by the membrane. The system 
allowed a strict control of the p02 at the myocardium level, 
using gas of selected composition. 
The mounting of the heart into the chamber took approx-
imately 30 minutes. After stabilization under normoxia (30 
minutes), the hearts were submitted to 30 minutes anoxia 
followed by 60 minutes reoxygenation (Fig. 1). In sham and 
paced groups the tested pharmacological agents were present 
throughout experiments at the concentrations indicated in 
Figure 2. 
All the experiments were performed in a standard 
HC03/C02 buffered medium composed of (in mmol/L): 
NaCl 99.25; NafüP04 0.3; NaHC03 10; KCl 4; MgCh 0.79; 
CaC12 1.5; D+glucose 8. This culture medium was equili-
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Figure 2. Cellular targets of the pharmaco-
logical approach. Agents and theirfinal con-
centration are indicated in italics. Activation 
or inhibition ofsarcolemmal (sarc-KATP) and 
L-type ca2+ channels can alter membrane po-
tential (Vin), action potential duration (APD ), 
and cytosofic Ca2+ ( [Ca2+] c ). Pharmacolog-
ical modulation of the mitochondrial KATP 
channel (mito-KATP) can influence mitochon-
drial pote11tial (Wm), calcium ([Ca2+ } 111 ), vol-
ume, ATP, and reactive oxygen species (ROS) 
production. Arrow means activation and T-
shaped symbol means inhibition ofchannels; 
broken fines indicate illferactions between 
sarc-KATP and L-type Ca2+ channels and be-
tween L-type Ca2+ and RyR channels (E-C 
coupfing). Dotted fines indicate the possible 
activation(+) or inactivation(-) of the chan-
nels by pacing. i.m. and o.m. = inner and outer 
mitochondrial membrane; E-C = excitation-
co!lfraction; RyRC = sarcoplasmic 1yanodine 
receptor channels. 
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brated inside the chamber with 2.31 % C02 in air (normoxia 
and reoxygenation) or in N2 (anoxia) yielding a pH of 7.4. 
In Vitro Recording of ECG and Cardiac Contractions 
Electrical and contractile activity of the embryonic hearts 
was recorded continuously throughout in vitro experiments. 
ECG recording was performed using two Ag/ AgCl electrodes 
(0 0.3 mm) 1 mm apart inserted into the window facing 
the culture compartment, as previously described. 10• 12 The 
atrial and ventricular regions were placed in the immediate 
vicinity of these electrodes that were connected to a differ-
ential preamplifier (gain of 2000), and the signal was digi-
tized and processed by a computer. Mechanical contraction 
(shortening) of atria and ventricle were optically detected as 
the edge motion of myocardial wall recorded simultaneously 
with ECG using a computerized setup. 12 The actual shorten-
ing was determined using video recordings performed before 
anoxia and at the end of reoxygenation. 
Functional Parameters 
E!ectrical activity 
The characteristic P, QRS, and T components of the em-
bryonic ECG were used to determine atrial (PP interval) 
and ventricular (RR interval) beating rate, QT duration, and 
PR interval reflecting the mean atrioventricular conduction 
delay. 
Contractile activity 
The shortening (µ,m) at the ventricular apex was de-
termined throughout anoxia-reoxygenation. The velocity of 
propagation of the wave of contraction between atria and 
ventricle, defined as the mechanical atrioventricular propa-
gation velocity (mm/s), was calculated from the actual dis-
tance between these regions divided by the atrioventricular 
mechanical delay obtained from the mechanical recording. 
E-C coupling 
The electromechanical delay (EMD, ms), reflecting the 
E-C coupling, was determined in atria (EMDa) and ventricle 
(EMDv) by measuring the interval between the initiation of 
the P and QRS components and the beginning of contraction 
in atria and ventricle, respectively. 
Protein Determination 
At the end of experiments, hearts were systematically dis-
sected into atria, ventricle, and conotruncus. Protein content 
of each cardiac region was determined according to Lowry 
et a!.22 using BSA as standard. 
Statistical Analysis 
Values are reported as mean ± standard error of the mean 
(SEM), unless otherwise indicated. The significance of any 
differences between sham and paced hearts was assessed 
with the unpaired Student's t-test, and that between treatment 
groups with ordinary ANOVA with Tukey-Kramer posthoc 
test. The significance of differences in functional recovery 
during reoxygenation was assessed using one-way analysis 
of variance (ANOVA) with repeated measures. The statistical 
significance was defined by a value of P < 0.05. 
Results 
In Ovo Cardiac Activity Before and After Pacing 
In a series of experiments, the spontaneous heart rate de-
termined in ovo before and after 12 hour of pacing increased 
from 157 ± 9 to 165 ± 12 (± SD; n = 17; P < 0.01, paired 
Student's t-test) and from 156 ± 9 to 161 ± 11 (± SD; n 
11; P < 0.02) in sham and paced hearts, respectively, with 
no statistical difference between sham and paced. The elec-
trical capture and intermittent stimulation did not affect the 
intrinsic heart rate. 
In Vitro Preanoxic Baseline Parameters 
After in vitro stabilization under normoxia, the functional 
parameters of the untreated sham and paced hearts did not 
differ (Table 1). The used pharmacological agents had no 
effect on cardiac activity except BAY-K, which had a positive 
chronotropic effect and affected E-C coupling (EMDv), and 
DIAZO, which slightly increased PR interval. 
Pacing Improved Postanoxic Recovery 
Relative to untreated sham hearts, the improvement of 
EMDv recovery (Fig. 3A) and the reduction of arrhythmias 
during the first 30 minutes of reoxygenation in untreated 
paced hearts (Fig. 3B) confirm our previous findings. 12 It 
should be noticed that during reoxygenation EMDv was 
the only functional parameter that was affected by pacing. 
Indeed, there was no chrono-, dromo-, or inotropic effect 
of pacing during anoxia-reoxygenation (Fig. 4 ). As recently 
characterized,23 reoxygenation-induced arrhythmias were es-
sentially brief cardioplegia, bursting activity, atrial ectopy, 
first-, second-, and third- degree AV blacks, ventricular es-
cape beats and Wenckebach phenomenon that disappeared 
after 30-55 minutes of reoxygenation. No pharmacological 
agent significantly altered incidence, type or duration of ar-
rhythmias observed in sham or paced hearts during reoxy-
genation. However, BAY-K and GLIB slightly, but not sig-
nificantly, prolonged arrhythmias (mainly AV blacks) in both 
experimental groups (not shown). Relative to other agents, 
BAY-K increased specifically the incidence of ventricular es-
cape beats in sham and paced hearts only during the first 
30 minutes of reoxygenation. 
Involvement of L-Type Ca2+, sarcKATP, and mitoKATP 
Channels in Pacing-Induced Protection 
In sham hearts, activation ofL-type Ca2+ channel by BAY-
K, inactivation of both sarcKATP and mitoKATP channels by 
GLIB or opening of mitoKATP channel by DIAZO had the 
same protective effect on EMDv as pacing (Fig. 5), with 
no significant impact on the other investigated parameters 
(Fig. 4). Rem1"rkably, none of these agents further im-
proved EMDv recovery in the paced hearts. After 60 min-
utes reoxygenation, heart rate, QT duration, PR interval, 
and atrioventricular mechanical propagation retumed to their 
baseline value, whatever the experimental conditions. How-
ever, ventricular shortening of the sham hearts was notice-
ably affected by VERAP and declined during reoxygenation 
(Fig. 4). Although EMDa recovery was delayed by BAY-K 
in paced but not in sham hearts, it retumed to its preanoxic 
level after 30 minutes of reoxygenation (not shown). 
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TABLE 1 
Baseline Parameter of Sham and Paced Hearts ln Vitro 
Verapamil Bay-K 5-HD GLIB DIAZO 
Untreated (lOnM) (1 µM) (500 µM) (lOµM) (100 µM) 
Heart rate (bpm) 
171±19 197 ± 24 215 ±24* 176 ± 36 200 ± 26 219 ± 49 
p 200 ± 17 264 ± 13•1 164 ± 35 210 ± 32 235 ± 26 
PR interval (ms) 
s 88 ± 21 96 ± 15 70 ± 11 89 ±4 98 ± 8 117 ± 11* 
p 85 ± 17 85 ±21 93 ± 9 109 ± 20 109 ± 13 
QT interval (ms) 
s 127 ± 22 103 ± 15 126 ± 18 125 ± 16 116±8 103 ± 11 
p 119 ± 10 109 ±7 133 ± 17 108 ±7 107 ± 12 
Mechanical AV delay (ms) 
s 108 ± 17 107 ±7 90 ± 11 113 ± 8 114± 14 129 ±Il 
p 100 ± 16 Ill± 27 112 ± 4 128 ±23 122 ± 15 
Atrial EMD (ms) 
s 17 ± 2 20 ± 5 17 ±4 16±4 16 ± 2 20 ± 2 
p 16±2 12 ± 5 15 ± 3 16 ± 2 20±2 
Ventricular EMD (ms) 
s 17 ±2 19 ± 3 23 ± 3* 20 ± 2 19±0 16±2 
p 20 ± 2 21 ±2 17 ± 5 19±0 18 ±2 
Ventricular shortening (/,un) 
s 62± 42 16± 12 50 ± 18 115 ± 23 54 ± 14 54 ± 25 
p 58 ± 28 60 ± 34 91±38 76±46 49 ±7 
Baseline parameters in sham (s) and paced (p) hearts. * P < 0.05 vs untreated, ANOVA; 1 P < 0.05 vs sham, unpaired Student's t-test; AV= atrio-ventricular; 
EMD = electro-mechanical delay; 5-HD = 5-hydroxydecanoate. 
Data are expressed as mean ± SD; n = 4 for each condition. 
Regional Protein Content 
The protein content in atria, ventricle, and conotruncus 
was the same in sham and paced hearts whatever the ex-
perimental conditions (atrium 20 ± 5.6 µ,g, ventricle 52.7 
± 10.2 µ,g, and conotruncus 10.7 ± 3.8 1;,,g; mean ± SD; 
n = 44). 
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Figure 3. Ventricular e/ectro-mechanical delay EMDv (A) and incidence of 
arrhythmias (B) of sham and paced hearts during anoxia and reo.<)'genation. 
Recove1y rate ofEMDvwas signijicantlyfaster in paced than in sham hearts. 
Remygenation-induced arrhythmias ceased earlier in paced hearts. EMDv 
was expressed as% ofpreanoxic value. Mean± SEM; *P < 0.05,ANOVA 
repeated measures; 11 = 4. 
Discussion 
Characteristics and Limitations of the M odel 
Chronic intermittent ventricular pacing at near physio-
logical rate induces myocardial remodeling and protection 
rapidly (few hours) in the embryonic heart model. 10- 12 The 
fact that the protein content in atria, ventricle, and conotrun-
cus was similar in ail experimental groups, indicates that 
12 hour of pacing did not affect the normal growth of the 
heart. The intrinsic heart rate of the developing embryo was 
not modified by in ovo pacing and the spontaneous beat-
ing rate of the isolated heart was the same in vitro as that 
measured in ovo, indicating that the spontaneous pacemaker 
activity was not altered by the chronic intermittent electri-
cal stimulation or the culture conditions. The thinness of 
the avascular wall (circa 200 µ,m) of the embryonic heart 
at the investigated stage allowed the pharmacological agents 
to diffuse readily into the myocardial tissue. These agents 
being present throughout anoxia-reoxygenation, it was not 
possible to discriminate between their specific action during 
anoxia or during reoxygenation. In particular, the pnsistence 
of arrhythmias in some hearts at the end of reoxygenation 
in the presence of BAY-K and GLIB could be partly ex-
plained by a long-lasting exposure to these potentially ar-
rhythmogenic agents. BAY-K was used at 1 µ,M as it did 
not cause major functional disturbances in our experimental 
conditions and prior studies carried on the properties of the 
L-type Ca2+ channels in embryonic chick cardiomyocytes 
have been performed in the same range of concentration, that 
is, 1-2 µ,M. 24-26 The precise detection of intracellular Ca2+ 
variations resulting from the pharmacological maneuvers or 
pacing was made difficult in our mode! because of the thick-
ness of the myocardium, the structural inhomogeneity of the 
ventricle (several cell layers, compact myocardium, trabec-
ulae, residual erythrocytes), and the motion of the ventricle 
wall during contractions. 
1200 Journal of Cardiovascular Electrophysiology Vol. 19, No. 11, November 2008 
A t) ahnm .. ahnm ' OUB o nham t D!A7.0 
<"i tham + VERAP 
B • paccd .. paccd + GUB o pnced + DIAZO 
x shnm + l3AY·K U ahum + 5·110 x pacOO + UAV·K 11 paeod ~ S·HO 
300 
, ANOXIA 
' 
250 b 
200 i, :\ 
150 :~ 
]>6,J" jL\!i/ig l fb 100 50 
300 
, ANOXIA 
' 
250 " ~~~ le•' 
100 
50 
•te'~< :~· 
: . 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
0 ,___,!~-~~!·~------~ 
200 
' :, " : . ' 
:.•. !: ;;!.~~~ 150 
1:: ~1 : ··~~,~ 
0 ,_._,·----~·--------
' 
' 1;~ ~ 
' 60 ~ 
40 ~~··. 
20 :·~ 
1 ..... 
0 l .-~ ·~. ·-··-~---;-- --
Figure 4. Variations of heart rate, PR inter-
val, and ventricular shortening (apex) in sham 
(A) and paced (B) hearts in the presence of 
the indicated pharmacological agents. None 
of the chrono-, dromo-, and inotropic param-
eters was sig11ijica11tly altered by paci11g (A vs 
B) or by the used agents. Note, howeve1; that 
verapamil tested in sham group had a 11otice-
able negative inotropic ejfect. Each time point 
represents the mean of four deternzinations. 
For the sake of clarity, SD bars are not repre-
sented on the graphs. 
70 80 90 100 110 120 130 40 50 60 70 80 90 100 110 120 130 
lime ln vitro (min) lime ln vitro (min) 
Pacing-Induced E-C Coupling Protection is Mimicked 
by Activation of the L-Type Ca2+ or mitoKArP Channels 
as well as by Inactivation of the sarcKATP 
Activation of L-type Ca2+ channel 
The transmembrane Ca2+ influx through L-type Ca2+ 
channels is required for cardiac E-C coupling and known 
to play a crucial role in normal heart development and func-
tion.27 Activation ofthese channels by anoxia-reoxygenation 
can also result in Ca2+ overload associated with arrhyth-
mias and contractile dysfonction in the embryonic heart.28·29 
In chick embryonic cardiomyocytes, BAY-K induces long-
lasting opening of L-type Ca2+ channel30 and increases am-
plitude and duration of the action potential with a slight pos-
itive chronotropic effect,31 ·32 which was also observed under 
our basal conditions. The combination of the atrial tachycar-
dia induced by BAY-K (Table 1) and the prolongation of PR 
interval (Fig. 4) and QT duration23 during anoxia and upon 
reoxygenation increases the risk of AV dissociation and/or 
ventricular escape beats in the embryonic heart that other-
wise Jacks specialized conduction system.33 As VERAP dras-
tically depressed ventricular contractility under normoxia, 
anoxia, and reoxygenation (shortening, Fig. 4A), it has not 
been tested in the paced group. 
In this work, a slight activation of the L-type Ca2+ chan-
nels by BAY-Kin sham hearts mimicked the pacing-induced 
protection of EMDv during reoxygenation with no effect on 
paced hearts. These findings clearly indicate that the prop-
erties and/or expression of the L-type Ca2+ channels in the 
ventricle were somewhat altered by pacing and suggest that 
the gain of E-C coupling can be increased by pacing at near 
physiological rate. 
Inactivation of sarcolemmal KArP channels 
The fact that the unspecific KATP channel blocker GLIB 
had an effect on EMDv recovery, unlike the mitoKATP chan-
nel blocker 5-HD, indicates that sarcKATP channels are also 
involved. Indeed, decreasing the opening probability of the 
sarcKATP channels with a concentration of GLIB that other-
wise does not alter the baseline parameters improved the re-
covery ofEMDv in sham hearts. This action mimicks the pro-
tective effect of pacing with no effect on recovery of EMDv in 
paced hearts. We hypothesize that inactivation of sarcKATP 
channels results in a slight membrane depolarization that, 
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in turn, can activate the L-type Ca2+ channels (as BAY-K di-
rectly does), increasing also intracellular Ca2+ and improving 
E-C coupling gain (see Fig. 2). 
Activation of the mitoKATP channel 
Recently, we have shown that mitoKATP channel activation 
by DIAZO in the postanoxic embryonic heart protects ven-
tricular EMD via NO-, ROS-, and PKC-dependent pathways, 
this protection being abolished by 5-HD.34 Here, the same 
DIAZO-mediated protection of EMD was observed in sham 
hearts but not in paced hearts, and 5-HD did not reverse the 
protection afforded by pacing. Our findings strongly support 
the hypothesis that the three investigated channels respond 
together in combination to chronic electrical stimulation and 
are ail involved in postanoxic protection. Consequently, in 
paced heart, pharmacologically targeting a specific channel 
(e.g., mitoKATP with 5-HD) should notnecessarilyreverse the 
effect of pacing. Mitochondria contribute also to myocardial 
Ca2+ homeostasis, 35 especially in the embryonic heart, 36 and 
opening of the mitoKATP channel can reduce Ca2+ electro-
chemical gradient and Ca2+ entry into mitochondria37 that, in 
turn, could contribute to maintain a higher level of cytosolic 
ca2+. 
In our experimental setting, it was not possible to deter-
mine whether L-type Ca2+ channel, sarcKATP, or mitoKATP 
play a predominant role in pacing-induced protection. 
Pacing-induced protection might resultfrom a moderate 
rise in intracellular calcium 
ln this study, BAY-K, GLIB, and DIAZO improved the 
postanoxic EMDv recovery in the sham hearts and not in 
paced hearts (Fig. 5). Through their different modes of ac-
tion, these agents can lead directly or indirectly to a moderate 
increase in intracellular calcium. The other tested drugs, that 
is, VERAP and 5-HD, which tend to diminish intracellular 
calcium, did not significantly affect the functional recovery 
after anoxia in sham hearts. On the basis of these observa-
tions and our findings, a possible interpretation is that a slight 
increase in calcium could indeed improve E-C coupling of 
the paced hearts in the setting of anoxia-reoxygenation. 
Besides the classical ischemic preconditioning, Ca2+ by 
itself could play a major raie in myocardial preconditioning, 
directly or as a second messenger altering gene expression. 15 
Furthermore, ischemic preconditioning is inhibited by L-type 
Ca2+ channel blockers. 17 In our mode!, the Ca2+ change in-
duced by pacing was expected to be small, much Jess than a 
Ca2+ overload, since we observed no additional contracture 
and no significant shortening aleration in paced hearts relative 
to sham, whatever the treatment. We propose that the dias-
tolic rather than the systolic Ca2+ concentration is altered, 
since we never observed an increase of ventricular shorten-
ing (strongly related to the peak of Ca2+ transient) under 
normoxia or during anoxia-reoxygenation in paced relative 
to sham hearts (Table 1, Fig. 4). Thus, a diastolic Ca2+ con-
centration slightly higher than the basal normoxic level but 
lower than a damaging Ca2+ overload38-40 could be cardio-
protective. The fact that recovery ofEMDv in the paced hearts 
could not be ameliorated by safe concentrations of BAY-K, 
GLIB, or DIAZO supports also this hypothesis. 
Finally, it should be noticed that the pacing-induced im-
provement of EMDv was observable exclusively during re-
oxygenation, whereas there was no detectable alteration un-
der normoxia in this experimental setting, showing that an 
anoxie stress was required to uncover the beneficial effect of 
pacing. 
Conclusion 
The protective effect of electrical stimulation at near phys-
iological rate on ventricular E-C coupling appears to be asso-
ciated with activation of L-type Ca2+ channel, inhibition of 
sarcKATP channel, and/or opening of mitoKATP channel. Ail 
these conditions can lead directly or indirectly to a moderate 
elevation of cellular Ca2+, suggesting that Ca2+ -dependent 
mechanisms may be involved in the protection afforded by 
pacing. 
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